Product Information

GLIPIZIDE 5 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.0350 per EA under NDC 62559031510. Its NADAC has been published 202 times since Oct 12, 2022.

FDA first approved this application on Aug 31, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GLIPIZIDE 5 MG TABLET

Glipizide
$0.0350per EA

Strength

5 mg/1

NDC

62559031510

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GLIPIZIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074497

FDA Approved

8/31/1995

TE Code

AB

On Market Since

5/31/2022

Pharmacological Classes

Sulfonylurea Compounds
Sulfonylurea

Price Statistics

The NADAC for GLIPIZIDE 5 MG TABLET has been published 202 times since Oct 12, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0350 per EA
All-time high$0.0363 (Dec 13, 2023)
All-time low$0.0252 (Nov 20, 2024)
52-week high$0.0360
52-week low$0.0346
Median price$0.0345
Average price$0.0340
Largest weekly change-26.1% (Nov 20, 2024)
Weeks tracked202
Tracking sinceOct 12, 2022

Price History

1W

-0.2%

1M

-0.2%

3M

-2.3%

6M

-1.8%

1Y

+1.2%

3Y

+0.5%

5Y

N/A

All

-0.5%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GLIPIZIDE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE 5 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.0350 per EA (NDC 62559031510), effective Aug 19, 2026.

How has the price of GLIPIZIDE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for GLIPIZIDE 5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 202 weekly CMS publications since Oct 12, 2022.

What are the highest and lowest recorded NADAC prices for GLIPIZIDE 5 MG TABLET?

Since Oct 12, 2022, the NADAC for GLIPIZIDE 5 MG TABLET has ranged from a low of $0.0252 (Nov 20, 2024) to a high of $0.0363 (Dec 13, 2023), with a median of $0.0345 per EA.

Are there cheaper alternatives to GLIPIZIDE 5 MG TABLET?

11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GLIPIZIDE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures GLIPIZIDE 5 MG TABLET?

GLIPIZIDE 5 MG TABLET (NDC 62559031510) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.